Role of aromatase in sex-specific cerebrovascular endothelial function in mice

Kristen L. Zuloaga, Catherine Davis, Wenri Zhang, Nabil Alkayed

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Stroke risk and outcome are strongly modified by estrogen. In addition to ovaries, estrogen is produced locally in peripheral tissue by the enzyme aromatase, and extragonadal synthesis becomes the major source of estrogen after menopause. Aromatase gene deletion in female mice exacerbates ischemic brain damage after stroke. However, it is not clear which cell type is responsible for this effect, since aromatase is expressed in multiple cell types, including cerebrovascular endothelium. We tested the hypothesis that cerebrovascular aromatase contributes to sex differences in cerebrovascular endothelial function. Cerebrocortical microvascular responses to the endothelium-dependent vasodilator ACh were compared between male and female wild-type (WT) and aromatase knockout (ArKO) mice by measuring laser-Doppler perfusion in vivo through a closed cranial window. Additional studies were performed in WT mice treated with the aromatase inhibitor fadrozole or vehicle. WT female mice had significantly greater responses to ACh compared with WT males (P <0.001), which was associated with higher aromatase expression in female compared with male cerebral vessels (P <0.05). ACh responses were significantly lower in ArKO compared with WT females (P <0.05) and in WT females treated with fadrozole versus vehicle (P <0.001). Conversely, ACh responses were significantly higher in ArKO versus WT males (P <0.05). Levels of phosphorylated endothelial nitric oxide synthase (eNOS) were lower in ArKO versus WT female brains, but were not altered by aromatase deletion in males. We conclude that cerebrovascular endothelial aromatase plays an important and sexually dimorphic role in cerebrovascular function and that aromatase inhibitors in clinical use may have cardiovascular consequences in both males and females.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume306
Issue number7
DOIs
StatePublished - Apr 1 2014

Fingerprint

Aromatase
Fadrozole
Aromatase Inhibitors
Estrogens
Stroke
Endothelium-Dependent Relaxing Factors
Nitric Oxide Synthase Type III
Gene Deletion
Brain
Menopause
Knockout Mice
Sex Characteristics
Endothelium
Ovary
Lasers
Perfusion

Keywords

  • Aromatase
  • CYP19
  • Endothelial
  • Sex differences
  • Vascular

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Role of aromatase in sex-specific cerebrovascular endothelial function in mice. / Zuloaga, Kristen L.; Davis, Catherine; Zhang, Wenri; Alkayed, Nabil.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 306, No. 7, 01.04.2014.

Research output: Contribution to journalArticle

@article{f2f3720e3abc4f9f950c482f6056136c,
title = "Role of aromatase in sex-specific cerebrovascular endothelial function in mice",
abstract = "Stroke risk and outcome are strongly modified by estrogen. In addition to ovaries, estrogen is produced locally in peripheral tissue by the enzyme aromatase, and extragonadal synthesis becomes the major source of estrogen after menopause. Aromatase gene deletion in female mice exacerbates ischemic brain damage after stroke. However, it is not clear which cell type is responsible for this effect, since aromatase is expressed in multiple cell types, including cerebrovascular endothelium. We tested the hypothesis that cerebrovascular aromatase contributes to sex differences in cerebrovascular endothelial function. Cerebrocortical microvascular responses to the endothelium-dependent vasodilator ACh were compared between male and female wild-type (WT) and aromatase knockout (ArKO) mice by measuring laser-Doppler perfusion in vivo through a closed cranial window. Additional studies were performed in WT mice treated with the aromatase inhibitor fadrozole or vehicle. WT female mice had significantly greater responses to ACh compared with WT males (P <0.001), which was associated with higher aromatase expression in female compared with male cerebral vessels (P <0.05). ACh responses were significantly lower in ArKO compared with WT females (P <0.05) and in WT females treated with fadrozole versus vehicle (P <0.001). Conversely, ACh responses were significantly higher in ArKO versus WT males (P <0.05). Levels of phosphorylated endothelial nitric oxide synthase (eNOS) were lower in ArKO versus WT female brains, but were not altered by aromatase deletion in males. We conclude that cerebrovascular endothelial aromatase plays an important and sexually dimorphic role in cerebrovascular function and that aromatase inhibitors in clinical use may have cardiovascular consequences in both males and females.",
keywords = "Aromatase, CYP19, Endothelial, Sex differences, Vascular",
author = "Zuloaga, {Kristen L.} and Catherine Davis and Wenri Zhang and Nabil Alkayed",
year = "2014",
month = "4",
day = "1",
doi = "10.1152/ajpheart.00698.2013",
language = "English (US)",
volume = "306",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "7",

}

TY - JOUR

T1 - Role of aromatase in sex-specific cerebrovascular endothelial function in mice

AU - Zuloaga, Kristen L.

AU - Davis, Catherine

AU - Zhang, Wenri

AU - Alkayed, Nabil

PY - 2014/4/1

Y1 - 2014/4/1

N2 - Stroke risk and outcome are strongly modified by estrogen. In addition to ovaries, estrogen is produced locally in peripheral tissue by the enzyme aromatase, and extragonadal synthesis becomes the major source of estrogen after menopause. Aromatase gene deletion in female mice exacerbates ischemic brain damage after stroke. However, it is not clear which cell type is responsible for this effect, since aromatase is expressed in multiple cell types, including cerebrovascular endothelium. We tested the hypothesis that cerebrovascular aromatase contributes to sex differences in cerebrovascular endothelial function. Cerebrocortical microvascular responses to the endothelium-dependent vasodilator ACh were compared between male and female wild-type (WT) and aromatase knockout (ArKO) mice by measuring laser-Doppler perfusion in vivo through a closed cranial window. Additional studies were performed in WT mice treated with the aromatase inhibitor fadrozole or vehicle. WT female mice had significantly greater responses to ACh compared with WT males (P <0.001), which was associated with higher aromatase expression in female compared with male cerebral vessels (P <0.05). ACh responses were significantly lower in ArKO compared with WT females (P <0.05) and in WT females treated with fadrozole versus vehicle (P <0.001). Conversely, ACh responses were significantly higher in ArKO versus WT males (P <0.05). Levels of phosphorylated endothelial nitric oxide synthase (eNOS) were lower in ArKO versus WT female brains, but were not altered by aromatase deletion in males. We conclude that cerebrovascular endothelial aromatase plays an important and sexually dimorphic role in cerebrovascular function and that aromatase inhibitors in clinical use may have cardiovascular consequences in both males and females.

AB - Stroke risk and outcome are strongly modified by estrogen. In addition to ovaries, estrogen is produced locally in peripheral tissue by the enzyme aromatase, and extragonadal synthesis becomes the major source of estrogen after menopause. Aromatase gene deletion in female mice exacerbates ischemic brain damage after stroke. However, it is not clear which cell type is responsible for this effect, since aromatase is expressed in multiple cell types, including cerebrovascular endothelium. We tested the hypothesis that cerebrovascular aromatase contributes to sex differences in cerebrovascular endothelial function. Cerebrocortical microvascular responses to the endothelium-dependent vasodilator ACh were compared between male and female wild-type (WT) and aromatase knockout (ArKO) mice by measuring laser-Doppler perfusion in vivo through a closed cranial window. Additional studies were performed in WT mice treated with the aromatase inhibitor fadrozole or vehicle. WT female mice had significantly greater responses to ACh compared with WT males (P <0.001), which was associated with higher aromatase expression in female compared with male cerebral vessels (P <0.05). ACh responses were significantly lower in ArKO compared with WT females (P <0.05) and in WT females treated with fadrozole versus vehicle (P <0.001). Conversely, ACh responses were significantly higher in ArKO versus WT males (P <0.05). Levels of phosphorylated endothelial nitric oxide synthase (eNOS) were lower in ArKO versus WT female brains, but were not altered by aromatase deletion in males. We conclude that cerebrovascular endothelial aromatase plays an important and sexually dimorphic role in cerebrovascular function and that aromatase inhibitors in clinical use may have cardiovascular consequences in both males and females.

KW - Aromatase

KW - CYP19

KW - Endothelial

KW - Sex differences

KW - Vascular

UR - http://www.scopus.com/inward/record.url?scp=84900561538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900561538&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00698.2013

DO - 10.1152/ajpheart.00698.2013

M3 - Article

C2 - 24508640

AN - SCOPUS:84900561538

VL - 306

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 7

ER -